Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 A phase 2a, open-label pilot study of the galectin-3 inhibitor GR-MD-02 for the treatment of moderate-to-severe plaque psoriasis.

× No keyword cloud information.

5 in total

Review 1. The Role of Galectins as Modulators of Metabolism and Inflammation.

Authors: Monica Fengsrud Brinchmann; Deepti Manjari Patel; Martin Haugmo Iversen
Journal: Mediators Inflamm Date: 2018-05-21 Impact factor: 4.711

Review 2. Galectin 3: an extraordinary multifunctional protein in dermatology. Current knowledge and perspectives.

Authors: Efstathia Pasmatzi; Christina Papadionysiou; Alexandra Monastirli; George Badavanis; Dionysios Tsambaos
Journal: An Bras Dermatol Date: 2019-07-29 Impact factor: 1.896

3. Enhancing clinical and immunological effects of anti-PD-1 with belapectin, a galectin-3 inhibitor.

Authors: Brendan D Curti; Yoshinobu Koguchi; Rom S Leidner; Annah S Rolig; Elizabeth R Sturgill; Zhaoyu Sun; Yaping Wu; Venkatesh Rajamanickam; Brady Bernard; Ian Hilgart-Martiszus; Christopher B Fountain; George Morris; Noriko Iwamoto; Takashi Shimada; ShuChing Chang; Peter G Traber; Eliezer Zomer; J Rex Horton; Harold Shlevin; William L Redmond
Journal: J Immunother Cancer Date: 2021-04 Impact factor: 13.751

Review 4. Galectin-3: an immune checkpoint target for musculoskeletal tumor patients.

Authors: Kosei Nakajima; Vitaly Balan; Avraham Raz
Journal: Cancer Metastasis Rev Date: 2020-09-14 Impact factor: 9.264

5. Galectin-3 as a Novel Multifaceted and Not Only Cardiovascular Biomarker in Patients with Psoriasis with Regard to Systemic Treatment-Preliminary Data.

Authors: Anna Baran; Paulina Kiluk; Julia Nowowiejska; Tomasz W Kaminski; Magdalena Maciaszek; Iwona Flisiak
Journal: Biology (Basel) Date: 2022-01-07

5 in total